Marcello Iriti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marcello Iriti has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Sara Vitalini
Department of Biomedical, Surgical and Dental Sciences Università degli Studi di Milano Milan Italy
72 shared publications - Franco Faoro
University of Milan
49 shared publications - Elena Maria Varoni
Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy
46 shared publications - Javad Sharifi-Rad
Universidad Espíritu Santo Samborondón Ecuador
39 shared publications - Abdur Rauf
Department of Chemistry, University of Swabi, Anbar, Pakistan
24 shared publications - Bahare Salehi
Student Research Committee, School of Medicine, Bam University of Medical Sciences, Bam 44340847, Iran
21 shared publications
Latest Publications
- Open Access
- 28 October 2026
- Published by Elsevier in Neuropharmacology
- Vol. 303
3,4-Dimethoxyacetophenone ameliorates epileptogenesis by suppressing BDNF, c-fos, and JAK-2/ STAT-3 expression in a pentylenetetrazole-induced kindling model of epilepsy
- 28 October 2026
- Published by Elsevier in Neuropharmacology
- Vol. 303
Open Access3,4-Dimethoxyacetophenone ameliorates epileptogenesis by suppressing BDNF, c-fos, and JAK-2/ STAT-3 expression in a pentylenetetrazole-induced kindling model of epilepsy
- Open Access
- 17 October 2026
- Published by Elsevier in Materials Today Communications
- Vol. 57
Bitter gourd flower extract-capped hydroxyapatite nanocomposite: A dual-function biomaterial for enhanced bone regeneration in diabetic conditions
- 17 October 2026
- Published by Elsevier in Materials Today Communications
- Vol. 57
Open AccessBitter gourd flower extract-capped hydroxyapatite nanocomposite: A dual-function biomaterial for enhanced bone regeneration in diabetic conditions
- Open Access
- 10 October 2026
- Published by Elsevier in South African Journal of Botany
- Vol. 198, 538-551
Sarcocephalobixin, a novel DPPH radical scavenger and antiplasmodial apocarotenoid from Nauclea latifolia Sm.: in vitro studies, molecular docking, molecular dynamics and drug-likeness prediction
- 10 October 2026
- Published by Elsevier in South African Journal of Botany
- Vol. 198, 538-551
Open AccessSarcocephalobixin, a novel DPPH radical scavenger and antiplasmodial apocarotenoid from Nauclea latifolia Sm.: in vitro studies, molecular docking, molecular dynamics and drug-likeness prediction
- Open Access
- 24 September 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (9) , e72373
Sea Medick Volatile Oil: Antioxidant, Insecticidal, In Vitro Cytotoxic Activity on SAF‐1 Cells and Anti‐Lipoxygenase Assessment via In Vitro and In Silico Methods
The Mediterranean plant Medicago marina L., native to North Africa, Spain, and Central Asia, is instrumental in the stabilization of coastal dunes and holds considerable economic significance. In addition to the plant's insecticidal potential against Tribolium castaneum , anti‐lipoxygenase activity, and cytotoxic activity against SAF‐1 cell lines, this study evaluated the antioxidant capacity of the essential oil, whose chemical composition was previously published in our paper. The observed antioxidant effect may be related to the reducing capacity and the strong electron donating properties of the essential oil components and may partially explain the insecticidal activity found, with a recorded 70.70% repellency after 1 h of exposure to the essential oil, compared with the control. The essential oil exhibited notable in vitro anti‐lipoxygenase activity, with an IC 50 value of 0.01 ± 0.002 μg mL −1 under the experimental conditions used. Moreover, molecular Docking outputs confirmed that the five main components of the essential oil bound well into the cavity of eukaryotic LOX‐5 enzyme. Additionally, SAF‐1 cell line cells were exposed to various concentrations of M. marina essential oil. The findings indicate that the viability of SAF‐1 cells was significantly affected only at a concentration of 5 mg mL −1 . In conclusion, in addition to being a natural source of anti‐inflammatory chemicals for pharmaceutical uses, Medicago marina essential oil may also be an environmentally beneficial way to keep stored goods safe from bug infestations. The biological activities observed may reflect the combined effects of the major constituents of the essential oil, particularly in relation to its pronounced insecticidal, cytotoxic, antioxidant and anti‐lipoxygenase effects.
- 24 September 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (9) , e72373
Open AccessSea Medick Volatile Oil: Antioxidant, Insecticidal, In Vitro Cytotoxic Activity on SAF‐1 Cells and Anti‐Lipoxygenase Assessment via In Vitro and In Silico Methods
The Mediterranean plant Medicago marina L., native to North Africa, Spain, and Central Asia, is instrumental in the stabilization of coastal dunes and holds considerable economic significance. In addition to the plant's insecticidal potential against Tribolium castaneum , anti‐lipoxygenase activity, and cytotoxic activity against SAF‐1 cell lines, this study evaluated the antioxidant capacity of the essential oil, whose chemical composition was previously published in our paper. The observed antioxidant effect may be related to the reducing capacity and the strong electron donating properties of the essential oil components and may partially explain the insecticidal activity found, with a recorded 70.70% repellency after 1 h of exposure to the essential oil, compared with the control. The essential oil exhibited notable in vitro anti‐lipoxygenase activity, with an IC 50 value of 0.01 ± 0.002 μg mL −1 under the experimental conditions used. Moreover, molecular Docking outputs confirmed that the five main components of the essential oil bound well into the cavity of eukaryotic LOX‐5 enzyme. Additionally, SAF‐1 cell line cells were exposed to various concentrations of M. marina essential oil. The findings indicate that the viability of SAF‐1 cells was significantly affected only at a concentration of 5 mg mL −1 . In conclusion, in addition to being a natural source of anti‐inflammatory chemicals for pharmaceutical uses, Medicago marina essential oil may also be an environmentally beneficial way to keep stored goods safe from bug infestations. The biological activities observed may reflect the combined effects of the major constituents of the essential oil, particularly in relation to its pronounced insecticidal, cytotoxic, antioxidant and anti‐lipoxygenase effects.
- Open Access
- 20 September 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (9) , e71743
Fatty Acid Composition of Fixed Oil of Linum strictum and Its Antibiofilm, Anticoagulant, and α‐Amylase Inhibitory Effects–In Vitro and In Silico Study
The present study investigated the fatty acid composition of Linum strictum seed oil and evaluated its antibacterial, antibiofilm, anticoagulant, and α‐amylase inhibitory activities. The oil was extracted from commercially obtained seeds and characterized by GC‐FID. Antibacterial activity was determined using the microbroth dilution method, while antibiofilm activity was assessed against multidrug‐resistant strains, including Pseudomonas aeruginosa , methicillin‐resistant Staphylococcus aureus (MRSA), and Acinetobacter baumannii . Anticoagulant effects were evaluated using prothrombin time (PT) and activated partial thromboplastin time (aPTT), and α‐amylase inhibition was assessed in vitro. The oil was characterized by a high proportion of unsaturated fatty acids, mainly α‐linolenic (57.08%), oleic (17.53%), and linoleic (14.0%) acids. Significant antibacterial activity was observed against Enterococcus faecalis ATCC 29212 and A. baumannii A2553 and A722 (MIC = 1.25 mg/mL), while three S. aureus strains showed MIC values of 5 mg/mL. Biofilm inhibition exceeded 70% against A. baumannii at 2×MIC. The oil prolonged coagulation times, particularly through the intrinsic pathway (PT = 16.4 s; aPTT = 81.6 s). α‐Amylase inhibition reached 85.98% (IC 50 = 0.0134 mg/mL), comparable to acarbose. Molecular docking revealed favorable binding of α‐oleic acid to BEL‐1 β‐lactamase and α‐linolenic acid to DNA gyrase B.
- 20 September 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (9) , e71743
Open AccessFatty Acid Composition of Fixed Oil of Linum strictum and Its Antibiofilm, Anticoagulant, and α‐Amylase Inhibitory Effects–In Vitro and In Silico Study
The present study investigated the fatty acid composition of Linum strictum seed oil and evaluated its antibacterial, antibiofilm, anticoagulant, and α‐amylase inhibitory activities. The oil was extracted from commercially obtained seeds and characterized by GC‐FID. Antibacterial activity was determined using the microbroth dilution method, while antibiofilm activity was assessed against multidrug‐resistant strains, including Pseudomonas aeruginosa , methicillin‐resistant Staphylococcus aureus (MRSA), and Acinetobacter baumannii . Anticoagulant effects were evaluated using prothrombin time (PT) and activated partial thromboplastin time (aPTT), and α‐amylase inhibition was assessed in vitro. The oil was characterized by a high proportion of unsaturated fatty acids, mainly α‐linolenic (57.08%), oleic (17.53%), and linoleic (14.0%) acids. Significant antibacterial activity was observed against Enterococcus faecalis ATCC 29212 and A. baumannii A2553 and A722 (MIC = 1.25 mg/mL), while three S. aureus strains showed MIC values of 5 mg/mL. Biofilm inhibition exceeded 70% against A. baumannii at 2×MIC. The oil prolonged coagulation times, particularly through the intrinsic pathway (PT = 16.4 s; aPTT = 81.6 s). α‐Amylase inhibition reached 85.98% (IC 50 = 0.0134 mg/mL), comparable to acarbose. Molecular docking revealed favorable binding of α‐oleic acid to BEL‐1 β‐lactamase and α‐linolenic acid to DNA gyrase B.
- Open Access
- 20 September 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (9)
Organ‐Specific Volatile Profiling of Lactuca tatarica (L.) C.A.Mey. (Asteraceae) Reveals Metabolic Differentiation by MSD–SPME–GC–MS/FID
The organ‐specific volatile profile of Lactuca tatarica (L.) C.A.Mey. (roots, leaves, and seeds), collected in Azerbaijan, was investigated using microsteam distillation–solid phase microextraction (MSD–SPME) coupled with gas chromatography–mass spectrometry/flame ionization detection (GC–MS/FID). A total of 46 compounds belonging to eight major chemical classes were identified. Clear organ‐dependent differences emerged: leaves exhibited the highest chemical diversity, with 34 constituents, and were dominated by lipid‐derived aldehydes; roots (21) showed a relative enrichment in terpenoids, while seeds displayed a simpler composition (16), mainly consisting of aldehydes and aromatic ketones. The predominant ones were phenylacetaldehyde in leaves (13.3%), hexanal in roots (18.0%), and nonanal in seeds (16.3%). These results highlight distinct metabolic differentiation reflected in the volatile profiles of the three organs and contribute to the phytochemical characterization of the genus Lactuca .
- 20 September 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (9)
Open AccessOrgan‐Specific Volatile Profiling of Lactuca tatarica (L.) C.A.Mey. (Asteraceae) Reveals Metabolic Differentiation by MSD–SPME–GC–MS/FID
The organ‐specific volatile profile of Lactuca tatarica (L.) C.A.Mey. (roots, leaves, and seeds), collected in Azerbaijan, was investigated using microsteam distillation–solid phase microextraction (MSD–SPME) coupled with gas chromatography–mass spectrometry/flame ionization detection (GC–MS/FID). A total of 46 compounds belonging to eight major chemical classes were identified. Clear organ‐dependent differences emerged: leaves exhibited the highest chemical diversity, with 34 constituents, and were dominated by lipid‐derived aldehydes; roots (21) showed a relative enrichment in terpenoids, while seeds displayed a simpler composition (16), mainly consisting of aldehydes and aromatic ketones. The predominant ones were phenylacetaldehyde in leaves (13.3%), hexanal in roots (18.0%), and nonanal in seeds (16.3%). These results highlight distinct metabolic differentiation reflected in the volatile profiles of the three organs and contribute to the phytochemical characterization of the genus Lactuca .
- Open Access
- 19 September 2026
- Published by Springer Nature in Phytochemistry Reviews
- p. 1-21
Evidence-based evaluation of berberine in neurodegenerative diseases: targeting multiple signaling pathways and modulating neuroinflammation, oxidative stress, and apoptosis
- 19 September 2026
- Published by Springer Nature in Phytochemistry Reviews
- p. 1-21
Open AccessEvidence-based evaluation of berberine in neurodegenerative diseases: targeting multiple signaling pathways and modulating neuroinflammation, oxidative stress, and apoptosis
- Open Access
- 1 September 2026
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 78 (9)
Phytochemical-mediated targeting of signaling pathways in glioblastoma: preclinical evidence, translational potential, and emerging nano-based therapeutic approaches
Objectives: Glioblastoma (GBM) is a highly aggressive brain cancer characterized by rapid growth, extensive infiltration, significant molecular diversity, and notable resistance to standard treatments, resulting in a poor prognosis for patients. This emphasizes the necessity for innovative therapeutic strategies based on novel mechanisms. Key findings: GBM tumorigenesis, glioma stem cell maintenance, immunological evasion, and treatment resistance are significantly influenced by the abnormal activation of various oncogenic signaling pathways, such as PI3K/Akt/mTOR, JAK/STAT, NF-κB, MAPK, Wnt/β-catenin, and receptor tyrosine kinases like EGFR and Axl. Phytochemicals such as quercetin, curcumin, resveratrol, and epigallocatechin gallate influence crucial signaling pathways in GBM by inhibiting specific pathways, inducing apoptosis and autophagy, suppressing glioma stemness, and modifying the tumor microenvironment. Furthermore, nano-based delivery systems such as dendrimers, lipid-based nanocarriers, polymeric nanoparticles, and biomimetic exosome-inspired systems enhance stability, bioavailability, and targeted delivery, thereby improving therapeutic efficacy. Summary: This review i) explores the potential of phytochemicals in targeting these pathways, ii) summarizes current evidence on phytochemicalmediated modulation of dysregulated signaling pathways in GBM, and iii) highlights emerging nanobased delivery strategies to improve therapeutic efficacy. Overall, phytochemical modulation of signaling pathways paired with nano-based drug delivery shows potential for enhancing treatment efficacy in GBM.
- 1 September 2026
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 78 (9)
Open AccessPhytochemical-mediated targeting of signaling pathways in glioblastoma: preclinical evidence, translational potential, and emerging nano-based therapeutic approaches
Objectives: Glioblastoma (GBM) is a highly aggressive brain cancer characterized by rapid growth, extensive infiltration, significant molecular diversity, and notable resistance to standard treatments, resulting in a poor prognosis for patients. This emphasizes the necessity for innovative therapeutic strategies based on novel mechanisms. Key findings: GBM tumorigenesis, glioma stem cell maintenance, immunological evasion, and treatment resistance are significantly influenced by the abnormal activation of various oncogenic signaling pathways, such as PI3K/Akt/mTOR, JAK/STAT, NF-κB, MAPK, Wnt/β-catenin, and receptor tyrosine kinases like EGFR and Axl. Phytochemicals such as quercetin, curcumin, resveratrol, and epigallocatechin gallate influence crucial signaling pathways in GBM by inhibiting specific pathways, inducing apoptosis and autophagy, suppressing glioma stemness, and modifying the tumor microenvironment. Furthermore, nano-based delivery systems such as dendrimers, lipid-based nanocarriers, polymeric nanoparticles, and biomimetic exosome-inspired systems enhance stability, bioavailability, and targeted delivery, thereby improving therapeutic efficacy. Summary: This review i) explores the potential of phytochemicals in targeting these pathways, ii) summarizes current evidence on phytochemicalmediated modulation of dysregulated signaling pathways in GBM, and iii) highlights emerging nanobased delivery strategies to improve therapeutic efficacy. Overall, phytochemical modulation of signaling pathways paired with nano-based drug delivery shows potential for enhancing treatment efficacy in GBM.
- Open Access
- 16 August 2026
- Published by Wiley in Phytotherapy Research
- Vol. 40 (10) , 5973-5987
Phytochemicals as Multitarget Therapeutics in Pancreatic Cancer: Mechanisms, Clinical Evidence, and Translational Challenges
Pancreatic cancer, especially pancreatic ductal adenocarcinoma, is known for its aggressive nature, late diagnosis, and resistance to standard treatments. This review demonstrates the therapeutic potential of phytochemicals as multitarget agents in pancreatic cancer, emphasizing their molecular mechanisms, pharmacological properties, and translational relevance. Important carcinogenic signaling pathways, such as KRAS/MAPK, PI3K/Akt, NF‐κB, STAT3, Hedgehog, and Wnt/β‐catenin, are modulated by phytochemicals like curcumin, quercetin, resveratrol, and others. These substances demonstrate anticancer effects by suppressing epithelial–mesenchymal transition, inducing apoptosis, reducing proliferation and angiogenesis, and modulating oxidative stress. Preclinical research indicates consistent multipathway targeting and potential enhanced efficacy with traditional chemotherapeutics, although evidence from clinical studies remains limited and inconsistent. New strategies to improve drug stability, target tumors more effectively, and enhance treatment outcomes involve the use of combination medicines and nanotechnology‐based delivery systems. The gap between preclinical effectiveness and clinical translation continues due to insufficient large‐scale trials, diverse study designs, and a lack of standardized dosing strategies. Phytochemicals show potential as multitarget treatments for pancreatic cancer, but their clinical application is inhibited by pharmacokinetic challenges and insufficient validation.
- 16 August 2026
- Published by Wiley in Phytotherapy Research
- Vol. 40 (10) , 5973-5987
Open AccessPhytochemicals as Multitarget Therapeutics in Pancreatic Cancer: Mechanisms, Clinical Evidence, and Translational Challenges
Pancreatic cancer, especially pancreatic ductal adenocarcinoma, is known for its aggressive nature, late diagnosis, and resistance to standard treatments. This review demonstrates the therapeutic potential of phytochemicals as multitarget agents in pancreatic cancer, emphasizing their molecular mechanisms, pharmacological properties, and translational relevance. Important carcinogenic signaling pathways, such as KRAS/MAPK, PI3K/Akt, NF‐κB, STAT3, Hedgehog, and Wnt/β‐catenin, are modulated by phytochemicals like curcumin, quercetin, resveratrol, and others. These substances demonstrate anticancer effects by suppressing epithelial–mesenchymal transition, inducing apoptosis, reducing proliferation and angiogenesis, and modulating oxidative stress. Preclinical research indicates consistent multipathway targeting and potential enhanced efficacy with traditional chemotherapeutics, although evidence from clinical studies remains limited and inconsistent. New strategies to improve drug stability, target tumors more effectively, and enhance treatment outcomes involve the use of combination medicines and nanotechnology‐based delivery systems. The gap between preclinical effectiveness and clinical translation continues due to insufficient large‐scale trials, diverse study designs, and a lack of standardized dosing strategies. Phytochemicals show potential as multitarget treatments for pancreatic cancer, but their clinical application is inhibited by pharmacokinetic challenges and insufficient validation.
- Open Access
- 22 July 2026
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (13) , 21411-21426
Pharmacokinetic evaluation and in vivo anti-inflammatory potential of cyanoacetate derivatives of succinimide
The purpose of the study is to evalute the in vivo anti -inflammatory activity of newly synthesized cyanoacetate derivatives of succinimides (C-23, C-31, and C-44) and to elucidate their possible mechanisms of action through key inflammatory mediator pathways. Anti-inflammatory activity was assessed using carrageenan-induced paw oedema and arachidonic acid-induced ear oedema models in vivo. Mechanistic involvement was investigated through histamine-, prostaglandin-, leukotriene-, and bradykinin-induced paw oedema assays. In silico ADME studies were performed to predict pharmacokinetic properties and metabolic interactions. All tested compounds exhibited significant anti-inflammatory activity, with C-44 showing the highest potency. Mechanistic studies indicated that the anti-inflammatory effects were predominantly mediated via inhibition of prostaglandin and leukotriene pathways. ADME predictions suggested high gastrointestinal absorption, favourable oral bioavailability, and minimal interaction with major metabolic enzymes. The synthesized cyanoacetate derivatives, particularly C-44, demonstrate promising anti-inflammatory potential with favourable pharmacokinetic profiles, supporting their candidacy for further development as effective anti-inflammatory agents.
- 22 July 2026
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (13) , 21411-21426
Open AccessPharmacokinetic evaluation and in vivo anti-inflammatory potential of cyanoacetate derivatives of succinimide
The purpose of the study is to evalute the in vivo anti -inflammatory activity of newly synthesized cyanoacetate derivatives of succinimides (C-23, C-31, and C-44) and to elucidate their possible mechanisms of action through key inflammatory mediator pathways. Anti-inflammatory activity was assessed using carrageenan-induced paw oedema and arachidonic acid-induced ear oedema models in vivo. Mechanistic involvement was investigated through histamine-, prostaglandin-, leukotriene-, and bradykinin-induced paw oedema assays. In silico ADME studies were performed to predict pharmacokinetic properties and metabolic interactions. All tested compounds exhibited significant anti-inflammatory activity, with C-44 showing the highest potency. Mechanistic studies indicated that the anti-inflammatory effects were predominantly mediated via inhibition of prostaglandin and leukotriene pathways. ADME predictions suggested high gastrointestinal absorption, favourable oral bioavailability, and minimal interaction with major metabolic enzymes. The synthesized cyanoacetate derivatives, particularly C-44, demonstrate promising anti-inflammatory potential with favourable pharmacokinetic profiles, supporting their candidacy for further development as effective anti-inflammatory agents.